The market, which was valued at $0.85 billion in 2024, is projected to grow to $0.91 billion in 2025, representing a compound annual growth rate CAGR of 7.2%. The growth during this historic period ...

Onychomycosis, in contrast to other routine superficial dermatophyte infections, is difficult to treat and poor outcomes are not unusual. Few guidelines for onychomycosis management have been ...

Both regulatory-approved and pipeline treatments for moderate to severe hidradenitis suppurativa demonstrate comparable ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published new, evidence-based clinical practice guidelines to support the treatment of chronic venous disease (CVD), a common and ...

Rates of Raynaud phenomenon medication initiation are low among patients with SSc in the United States, with less than one-third receiving consistent treatment.

Panelists discuss how chronic neuroinflammation involves distinct mechanisms from acute relapses—including microglial ...

Rheumatoid arthritis (RA) is an autoimmune disease that causes joint pain and inflammation. The condition is chronic, and there’s no cure. However, in recent years, new treatment options have ...

A new study by scientists at the University of Colorado Anschutz Medical Campus reveals that joint tissue from patients with ...

If your yeast infection didn’t respond to the first course of treatment, your doctor may prescribe long-term antifungals. This may include weekly oral or vaginal medications for up to 6 months.